Recall Record

Boston, MA, United States

TEI Biosciences, Inc. recalls

2 recalls recorded since 2018, most recently on 23 May 2023. 1 is listed as ongoing. Status and classification are as published by the FDA.

Recalls2
Ongoing (FDA)1
Terminated or completed1
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
23 May 2023
Reason
Possible out of specification endotoxin test results due to issues with in-process and finished goods endotoxin testing.
Distribution
Domestic: Nationwide Distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2082-2023, Z-2076-2023, Z-2074-2023, Z-2071-2023, Z-2078-2023, Z-2080-2023, Z-2077-2023, Z-2081-2023, Z-2083-2023, Z-2084-2023, Z-2073-2023, Z-2069-2023 and 5 more

Terminated Class II Medical devices

Recall started
15 June 2017
Terminated
15 March 2018
Reason
During Final Assembly Operation, it was noticed that some of the PriMatrix Instructions for Use (IFUs) from Lot RM1608011 Part 520-002v10 contained extra pages and/or missing pages: " 22 IFUs contained duplicate pages 15 - 26 & 51 - 62 and were also missing pages 27 - 50 " 3 IFUs were missing pages 27 - 50 " 1 IFU was missing pages 1 - 2 & 75 - 76 " 1 IFU was missing pages 15 - 62 While pages 27  50, 75  76, and 15  62 contain instructions written in a language other than English, pages 1  2 contain information regarding the indications for use, contraindications, device description, warning and precautions, and potential complications of the device.
Distribution
U.S.
Initiated
Voluntary: Firm initiated
Recall number
Z-0383-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.